封面
市場調查報告書
商品編碼
1544653

玻璃化市場、機會、成長動力、產業趨勢分析與預測,2024-2032

Vitrification Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在不孕率不斷上升的推動下,玻璃化冷凍市場規模從 2024 年到 2032 年的複合年成長率預計將達到 10.1%。玻璃化冷凍是保存胚胎和卵母細胞的關鍵技術,可以保護那些面臨生育問題的人的生殖選擇。為了滿足生育治療不斷成長的需求,研究人員和臨床醫生正在對玻璃化冷凍過程進行微調。這些增強功能不僅提高了生育手術的成功率,也為面臨不孕症挑戰的個人提供了強而有力的支持。根據世界衛生組織最近的報告,全球約有六分之一的人患有不孕症。這種上升趨勢正在推動玻璃化冷凍方法的採用,旨在提高輔助生殖治療的成功率。

玻璃化產業分為產品類型、樣本、最終用途和地區。

試劑盒產品類型細分市場的市場佔有率將在2024 年至2032 年間錄得可觀的成長率。 。這種快速冷卻可以最大限度地減少冰的形成,而冰的形成是細胞和組織活力的關鍵因素。玻璃化試劑盒在幹細胞儲存和胚胎保存等應用中也發揮關鍵作用,可微調冷卻速率和配方以提高保存成功率。

就標本而言,預計 2024 年至 2032 年胚胎玻璃化市場將出現顯著的複合年成長率。這種生長是由保存胚胎、抑製冰晶形成和潛在細胞損傷的必要性所驅動的。隨著玻璃化冷凍方案的不斷完善,研究人員的目標是提高胚胎保存和植入的成功率。這些進步有望提供更有效、更可靠的胚胎保存方法,與生育治療和生殖健康的發展保持一致。

由於政府措施和資金的增加,到 2032 年,亞太地區玻璃化產業規模將創下顯著的複合年成長率。許多政府都支持冷凍保存技術研究,包括玻璃化冷凍,以促進生育治療和生殖健康。這些措施旨在利用財政援助和資源來提高技術及其成功率。這種堅定不移的支持凸顯了玻璃化冷凍在推動亞太地區生殖保健方面的關鍵作用。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 生育治療的需求不斷增加
      • 擴大生物樣本庫領域
      • 對體外受精的認知與接受度不斷提高
      • 冷凍保存技術的進步
    • 產業陷阱與挑戰
      • 玻璃化冷凍過程成本高
      • 嚴格的監管要求
  • 成長潛力分析
  • 監管環境
  • 定價分析
  • 未來市場趨勢
  • 技術景觀
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品類型,2021 - 2032 年

  • 主要趨勢
  • 裝置
    • 開放系統
    • 封閉系統
  • 套件
  • 試劑及耗材

第 6 章:市場估計與預測:按樣本,2021 - 2032

  • 主要趨勢
  • 胚胎
  • 卵母細胞
  • 精子

第 7 章:市場估計與預測:按最終用途,2021 - 2032 年

  • 主要趨勢
  • 體外受精診所
  • 生物樣本庫

第 8 章:市場估計與預測:按地區分類,2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章:公司簡介

  • Biotech, Inc.
  • CooperSurgical Fertility Company
  • FERTIPRO NV
  • FUJIFILM Irvine Scientific
  • Genea BIOMEDX
  • IMV Technologies Group (Cryo Bio System)
  • Kitazato Corporation.
  • MFC Global
  • MINITUB GMBH
  • NidaCon International AB
  • Optimas
  • Shenzhen VitaVitro Biotech
  • Vitrolife
簡介目錄
Product Code: 10188

Vitrification Market size is set to record a 10.1% CAGR from 2024 to 2032 driven by escalating infertility rates. Vitrification serves as a pivotal technique for preserving embryos and oocytes for safeguarding reproductive choices for those grappling with fertility issues. In response to the surging demand for fertility treatments, researchers and clinicians are fine-tuning the vitrification process. These enhancements not only bolster the success rates of fertility procedures but also offer robust support to individuals facing infertility challenges. According to a recent WHO report, approximately 1 in 6 individuals globally contend with infertility. This rising trend is propelling the adoption of vitrification methods, aiming to boost success rates in assisted reproductive treatments.

The vitrification industry is segmented into product type, specimen, end-use, and region.

The market share from the kits product type segment will record a decent growth rate between 2024 and 2032. This surge is attributed to the increasing demand for biological sample preservation, achieved by swiftly cooling samples to a glass-like state. Such rapid cooling minimizes ice formation, a crucial factor for the viability of cells and tissues. Vitrification kits also play a pivotal role in applications like stem cell storage and embryo preservation for fine-tuning cooling rates and formulations to enhance preservation success rates.

In terms of specimen, the vitrification market from the embryos segment is anticipated to witness a significant CAGR from 2024-2032. This growth is driven by the imperative to preserve embryos, curbing ice crystal formation and potential cell damage. With ongoing refinements in vitrification protocols, researchers aim to boost embryo preservation and implantation success rates. These advancements promise more effective and dependable embryo preservation methods, aligning with the evolution of fertility treatments and reproductive health.

Asia Pacific vitrification industry size will record a significant CAGR through 2032 due to rising government initiatives and funding. Numerous governments are backing cryopreservation technology research, including vitrification, to bolster fertility treatments and reproductive health. With financial assistance and resources at their disposal, these initiatives aim to elevate technology and its success rates. Such unwavering support underscores the pivotal role of vitrification in advancing reproductive healthcare in APAC.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing demand for fertility treatment
      • 3.2.1.2 Expanding biobanking sector
      • 3.2.1.3 Rising awareness and acceptance of IVF
      • 3.2.1.4 Advancements in cryopreservation technologies
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of vitrification procedure
      • 3.2.2.2 Stringent regulatory requirements
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Pricing analysis
  • 3.6 Future market trends
  • 3.7 Technology landscape
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Devices
    • 5.2.1 Open system
    • 5.2.2 Closed system
  • 5.3 Kits
  • 5.4 Reagents and consumables

Chapter 6 Market Estimates and Forecast, By Specimen, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Embryos
  • 6.3 Oocytes
  • 6.4 Sperms

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 In vitro fertilization clinics
  • 7.3 Biobanks

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 The Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Biotech, Inc.
  • 9.2 CooperSurgical Fertility Company
  • 9.3 FERTIPRO NV
  • 9.4 FUJIFILM Irvine Scientific
  • 9.5 Genea BIOMEDX
  • 9.6 IMV Technologies Group (Cryo Bio System)
  • 9.7 Kitazato Corporation.
  • 9.8 MFC Global
  • 9.9 MINITUB GMBH
  • 9.10 NidaCon International AB
  • 9.11 Optimas
  • 9.12 Shenzhen VitaVitro Biotech
  • 9.13 Vitrolife